Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $1 Equals the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 1.09||$ 7.3512|
|Low:||$ 0.902||$ 1|
Company Description (as filed with the SEC)
Aradigm Corporation (the "Company," "our company," "we," "our," or "us") are an emerging specialty pharmaceutical company focused on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. Over the last decade, we invested a large amount of capital to develop drug delivery technologies, particularly the development of a significant amount of expertise in respiratory (pulmonary) drug delivery as incorporated in our lead product candidate that recently completed two Phase 3 clinical trials, Linhaliq inhaled ciprofloxacin, formerly known as Pulmaquin®. The key asset we have focused our efforts on in recent years is our inhaled ciprofloxacin formulations. We believe that our cash and cash equivalents of approximately $7.1 million as of December 31, 2017, will only be sufficient to fund our operations for the first quarter of 2018. ... More ...
Nasdaq Official Price
Nov. 16, 2018
Nov. 16, 2018